Skip to main content
AVNS logo

Avanos Medical, Inc.

AVNSNYSEHealthcareMedical Devices

$24.99Today:- (-)1Y +111.96%

As of Jul 24, 2026 close

Market cap
$1.19B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.64$25.49
Volume (live)
-
Avg. volume (3M)
2.06M

AVNS was delisted on Oct 24, 2026. Data shown is historical and no longer updated.

Avanos Medical (AVNS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Avanos Medical generated $74.70M of operating cash flow and spent $31.60M on capital expenditures. That left free cash flow of $43.10M, down 48.0% from $82.90M a year earlier, or 6.1% of revenue. It repurchased $3.30M of its own shares.

Avanos Medical Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Avanos Medical, Inc. (AVNS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-72.90-392.10-61.8050.505.20-29.00-45.9057.5079.30
Depreciation & Amortization38.9045.5046.1047.7038.3042.9036.9033.5059.50
Deferred Income Tax0.000.000.000.00-3.4025.90-6.503.70-6.20
Stock Based Compensation12.6013.8015.8015.9013.2012.1010.5010.5012.60
Change in Working Capital9.8035.00-18.00-24.3026.00-65.40-59.60-143.40-4.30
Change in Accounts Receivable30.90-6.6039.00-24.70-10.8045.80-0.8067.40-15.30
Change in Inventory0.2039.004.70-30.9017.20-19.40-21.30-34.50-16.80
Change in Accounts Payable0.60-0.90-14.4035.40-11.90-18.90-83.60-64.0018.80
Change in Other Working Capital-21.903.50-47.30-4.1031.50-72.9046.10-112.309.00
Other Operating Activities86.30398.5050.301.108.0013.20-9.90-107.403.30
Net Cash from Operating Activities74.70100.7032.4090.9087.30-2.50-74.50-145.60144.20
Investing Activities
Capital Expenditures-31.60-17.80-17.80-19.30-21.00-20.20-50.60-49.10-43.20
Acquisitions-28.00-9.7039.40-116.100.00-4.00-57.50688.600.10
Other Investing Activities-1.000.000.000.000.000.000.00754.300.10
Net Cash from Investing Activities-60.60-27.5021.60-135.40-21.00-24.20-108.10639.50-43.10
Financing Activities
Debt Repayment-34.40-33.60-64.70103.40-50.00-254.80-0.20-339.000.00
Common Stock Issued0.700.000.000.000.003.400.000.000.00
Common Stock Repurchased-3.30-12.80-19.10-45.50-11.50-0.90-3.60-0.90-2.50
Other Financing Activities0.00-2.70-10.40-1.206.20-2.705.3015.504.70
Net Cash from Financing Activities-37.00-49.10-94.2056.70-55.30-70.001.50-324.402.20
Summary
Effect of Forex Changes on Cash5.00-4.100.20-3.00-4.002.901.90-4.702.70
Net Change in Cash-17.9020.00-40.009.207.00-93.80-179.20164.80106.00
Cash at Beginning of Period107.7087.70127.70118.50111.50205.30384.50219.70113.70
Cash at End of Period89.80107.7087.70127.70118.50111.50205.30384.50219.70
Free Cash Flow43.1082.9014.6071.6066.30-22.70-125.10-194.70101.00
Supplemental Disclosures
Interest Paid-11.5014.708.103.0016.80---
Income Taxes Paid-3.3023.60-2.90-45.00----

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Avanos Medical Cash Flow

What is Avanos Medical's free cash flow?

Avanos Medical generated free cash flow of $43.10M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $74.70M minus $31.60M of capital expenditures. That was down 48.0% from $82.90M a year earlier. Free cash flow equaled 6.1% of revenue.

How much does Avanos Medical spend on capital expenditures?

Avanos Medical spent $31.60M on capital expenditures in fiscal 2025, compared with $17.80M a year earlier. That equals 42.3% of operating cash flow.

Does Avanos Medical pay dividends or buy back shares?

Yes. In fiscal 2025 Avanos Medical returned $3.30M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition